Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura.

作者: György Sinkovits , Ágnes Szilágyi , Péter Farkas , Dóra Inotai , Anikó Szilvási

DOI: 10.3389/FIMMU.2018.01646

关键词:

摘要: Background: The acquired form of idiopathic thrombotic thrombocytopenic purpura (TTP) is an autoimmune disease, in which the underlying deficiency ADAMTS13 protease caused by autoantibodies, predominantly IgG isotype. Certain HLA-DR-DQ haplotypes were associated with risk developing TTP. Objectives: To investigate development ADAMTS13-specific antibody response during course we analyzed concentration, subclass distribution, and inhibitory potential anti-ADAMTS13 autoantibodies samples TTP patients drawn first acute phase, remission, relapse. Additionally, compared levels between carrying not protective haplotypes. Patients methods: We determined concentration distribution 101 antibody-positive 81 ELISA methods. presence semi-quantitative amount inhibitors 97 100 deficient samples, specific 49 selected mixing activity assays. typing haplotype prediction performed 70 above patients. Results: found that IgG1 IgG4 predominant subclasses, present almost all samples. While was dominant half taken episode, or following a correlated subclass. Anti-ADAMTS13 antibodies IgG4-dominant had higher potentials than IgG1-dominant independently disease stage. Interestingly, DR7-DQ2 DR13-DQ6 levels. Conclusion: Our results indicate becomes subtype at some point course, apparently before relapse, parallel to increase autoantibodies. Furthermore, association genetic background

参考文章(43)
Miha Furlan, Rodolfo Robles, Max Solenthaler, Max Wassmer, Pierre Sandoz, Bernhard Lämmle, Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura Blood. ,vol. 89, pp. 3097- 3103 ,(1997) , 10.1182/BLOOD.V89.9.3097
J S van der Zee, R C Aalberse, P van Swieten, Serologic aspects of IgG4 antibodies. II: IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency Journal of Immunology. ,vol. 137, pp. 3566- 3571 ,(1986)
G. BETTONI, R. PALLA, C. VALSECCHI, D. CONSONNI, L. A. LOTTA, S. M. TRISOLINI, I. MANCINI, K. M. MUSALLAM, F. R. ROSENDAAL, F. PEYVANDI, ADAMTS‐13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura Journal of Thrombosis and Haemostasis. ,vol. 10, pp. 1556- 1565 ,(2012) , 10.1111/J.1538-7836.2012.04808.X
R C Aalberse, J van Leeuwen, R van der Gaag, Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. Journal of Immunology. ,vol. 130, pp. 722- 726 ,(1983)
Mari R. Thomas, Rens de Groot, Marie A. Scully, James T.B. Crawley, Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura EBioMedicine. ,vol. 2, pp. 942- 952 ,(2015) , 10.1016/J.EBIOM.2015.06.007
Silvia Ferrari, Friedrich Scheiflinger, Manfred Rieger, Geert Mudde, Martine Wolf, Paul Coppo, Jean-Pierre Girma, Elie Azoulay, Christian Brun-Buisson, Fadi Fakhouri, Jean-Paul Mira, Eric Oksenhendler, Pascale Poullin, Eric Rondeau, Nicolas Schleinitz, Benoit Schlemmer, Jean-Louis Teboul, Philippe Vanhille, Jean-Paul Vernant, Dominique Meyer, Agnès Veyradier, , Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity Blood. ,vol. 109, pp. 2815- 2822 ,(2007) , 10.1182/BLOOD-2006-02-006064
Nicoletta Sorvillo, Simon D. van Haren, Paul H. Kaijen, Anja ten Brinke, Rob Fijnheer, Alexander B. Meijer, Jan Voorberg, Preferential HLA-DRB1*11–dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells Blood. ,vol. 121, pp. 3502- 3510 ,(2012) , 10.1182/BLOOD-2012-09-456780
Xinglong Zheng, Dominic Chung, Thomas K. Takayama, Elaine M. Majerus, J. Evan Sadler, Kazuo Fujikawa, Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura Journal of Biological Chemistry. ,vol. 276, pp. 41059- 41063 ,(2001) , 10.1074/JBC.C100515200
S. FERRARI, G. C. MUDDE, M. RIEGER, A. VEYRADIER, J. A. KREMER HOVINGA, F. SCHEIFLINGER, IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. ,vol. 7, pp. 1703- 1710 ,(2009) , 10.1111/J.1538-7836.2009.03568.X